(HealthDay)—For patients with alopecia areata (AA), superficial hypothermic cryotherapy is effective, especially when the treatment interval is two weeks or less, according to research published online Oct. 6 in the Journal ...
Oct 12, 2016
0
0
Seasonal influenza is a global public health concern. The World Health Organization estimates 3-5 million cases of severe infection annually, resulting in up to half a million deaths. In industrialized countries, people aged ...
Oct 12, 2016
0
0
Each year, influenza causes between 250,000 and half a million deaths around the world. Pregnant women and young infants have a higher risk of complications related to influenza; these complications can easily lead to death. ...
Jun 2, 2016
0
97
A dengue vaccine candidate by French drugmaker Sanofi protects more than three quarters of participants, an analysis found Monday.
Jul 28, 2015
0
40
New research finds that misdiagnoses lead to increased risk of incorrect antibiotic use, threatening patient outcomes and antimicrobial efficacy, while increasing healthcare costs. The study was published online today in ...
May 18, 2015
0
31
(HealthDay)—A subunit vaccine containing varicella-zoster virus glycoprotein E and the AS01B adjuvant system (HZ/su) is efficacious against herpes zoster infection in older adults, according to a study published online ...
Apr 30, 2015
0
7
The first malaria vaccine candidate (RTS,S/AS01) to reach phase 3 clinical testing is partially effective against clinical disease in young African children up to 4 years after vaccination, according to final trial data, ...
Apr 24, 2015
0
68
Among patients with the systemic autoimmune disease primary Sjögren syndrome, use of hydroxychloroquine, the most frequently prescribed treatment for the disorder, did not improve symptoms during 24 weeks of treatment compared ...
Jul 15, 2014
0
0
Pretreating the site of intradermal vaccination – vaccine delivered into the skin rather than to muscles beneath the skin – with a particular wavelength of laser light may substantially improve vaccine effectiveness without ...
Dec 11, 2013
0
0
Results from a large-scale Phase III trial, presented today in Durban, show that the most clinically advanced malaria vaccine candidate, RTS,S, continued to protect young children and infants from clinical malaria up to 18 ...
Oct 7, 2013
1
0
